Advertisement

B.C. becomes 1st province in Canada to pay for Paxlovid

Click to play video: 'Health Matters: COVID cases on the rise in BC and does Paxlovid work?'
Health Matters: COVID cases on the rise in BC and does Paxlovid work?
As we enter the fall season, COVID-19 cases are on the rise. Medical contributor Dr. Birinder Narang has more on that plus the latest on the effectiveness of the antiviral medication Paxlovid – Sep 23, 2023

British Columbia is the first province in Canada to be paying for the COVID-19 medication Paxlovid.

The federal government has told all provinces it will no longer be paying for the drug used to treat COVID-19. Other provinces are moving the drug to the pharmacare program.

Paxlovid is an anti-viral medication approved by Health Canada in January 2022 for the treatment of mild to moderate COVID-19 in adults at high risk for progression to severe COVID-19 outcomes.

Receive the latest medical news and health information delivered to you every Sunday.

Get weekly health news

Receive the latest medical news and health information delivered to you every Sunday.
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.

The medication is recommended for people at higher risk of serious illness and hospitalization and treatment must begin within five days of the start of symptoms to be effective.

Click to play video: 'COVID-19: Canadian study reveals that Paxlovid prevents severe illness'
COVID-19: Canadian study reveals that Paxlovid prevents severe illness

In addition, a COVID-19 booster remains available in B.C. for those most at risk of severe illness or complications and for those who have not yet received an updated vaccine dose.

Story continues below advertisement

However, anyone who feels they would benefit from an additional dose of the XBB.1.5 COVID-19 vaccine can contact the call centre at 1-833-838-2323 to book an appointment or walk into a pharmacy where the vaccine is available, the government said in a release.

Sponsored content

AdChoices